Glenn Gregory M 4
4 · NOVAVAX INC · Filed Dec 16, 2022
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Glenn Gregory M
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-12-14$17.23/sh−1,033$17,799→ 8,009 total - Exercise/Conversion
Common Stock
2022-12-14+3,100→ 9,042 total - Exercise/Conversion
Restricted Stock Units
2022-12-14−3,100→ 3,100 total→ Common Stock (3,100 underlying)
Footnotes (6)
- [F1]The shares were received by the Reporting Person in connection with vesting of restricted stock units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F3]Includes 278 shares acquired on January 31, 2022 and 1 share acquired on July 31, 2022, each under the Company's Amended and Restated 2013 Employee Stock Purchase Plan, as amended.
- [F4]The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs.
- [F5]The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022.
- [F6]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.